Drug-Drug Interaction Study Evaluating Effects of ASP015K on Rosuvastatin

Clinical trial NCT01959399 · COMPLETED

Trial details

NCT number: NCT01959399
Sponsor: Astellas Pharma Global Development, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects Pharmacokinetics of ASP015K

Start date: 2013-05-01
Primary completion: 2013-07-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.